COMPANY DETAILS

Aker BioMarine

Oksenøyvn. 10 (Bygg B)

1366 Lysaker

Norway

 

www.akerbiomarine.com

superba@akerbiomarine.com

 

Tel. +47 24 13 00 10

ACTIVE CATEGORIES

Nutraceutical and Functional Food Ingredients

Aker BioMarine

Aker BioMarine is an integrated biotechnology company – uniquely positioned to create value krill derived biotech products. The company is supplying biomarine ingredients through an optimized value chain from raw materials to customer.

Aker BioMarine utilizes its unique krill harvesting to develop its own downstream operations within the high value added nutraceutical and aquaculture feed markets.

Krill derived products, such as oil and meal, have a high content of bioactive ingredients, e.g. Omega-3 bound phospholipids and astaxanthin, which have documented positive effects on both humans and animals.

Aker BioMarine has registered Superba as the company`s brand name for nutraceutical and Qrill as the company’s brand name for its krill meal and krill oil products for aquaculture. Qrill has proven benefits to competing products in the aquaculture market. 

Following the merger with Natural in June 2007, Aker BioMarine has a wide set of capabilities within nutraceuticals (dietary supplements and functional foods) and is an experienced player in nutraceutical applications of lipids, product development, and intellectual property rights (IPR), R&D and product commercialization.

Products / Markets supplier image

Nutrition & Health Aker BioMarine has registered Superba as the company`s brandnames for its krill oil products for the human market. The Omega-3 phospholipids and astaxanthin found in krill promote among others physical and mental health.

Aker BioMarine has registered Qrill as the company’s brand name for its krill meal and krill oil products for aquaculture feed markets. Business activities have already succeeded in establishing a broad customer base in the market for Qrill meal deliveries to the aquaculture industry.


supplier banner image

Articles On NutritionInsight

Collapse

Business News   09 August 2017

Aker BioMarine and Neptune close US$34m transaction to accelerate krill oil industry

09 Aug 2017 --- Neptune Technologies & Bioressources Inc. and Aker BioMarine Antarctic AS have concluded an agreement whereby Aker BioMarine has acquired Neptune’s krill oil inventory and IP for a cash consideration of US$34 million, paid at closing.

Business News   05 May 2017

After "Challenging" 2016 Results, Aker BioMarine Highlights New Investments and Sustainability

05 May 2017 --- Krill supplier Aker BioMarine has reported revenues of US$117 million in 2016 compared with US$105 million in 2015, which is equivalent to 11 percent growth. The operating profit before depreciation and special operating items (EBITDA) amounted to US$36 million in 2016, according to the company’s latest annual report. The company managed to grow sales and improve operations in the still-challenging omega 3 market, and continues to heavily invest in new technology and the development of new krill-derived products, the company reported.

Nutrition & Health News   15 February 2017

Aker BioMarine Invest in Sustainable Krill Fishing Vessel

15 Feb 2017 --- Aker BioMarine has awarded a contract to VARD to build a state-of-the-art krill-fishing vessel that will fish in the Antarctic. The company say that, “it is the largest single contract VARD has ever received for a fishing vessel, and we are very happy to have entered a shipbuilding contract with them.”

More Articles

Video Interviews

Collapse

18 May 2017

Market Opportunities in Krill Oil

Aker BioMarine recently reported how the company managed to grow sales and improve operations in the still-challenging omega-3 market, and continues to heavily invest in new technology and the development of new krill-derived products. Matts Johansen, CEO of Aker BioMarine, is satisfied with the result, but admitted that 2016 was still a challenging year for the company. Johansen said. “Although 2016 was a good year for Aker BioMarine, we posted slightly negative earnings after tax. The investments needed to build a supply chain for krill-based products, the resources needed to innovate and document their biological effects, and the time needed to develop new markets are reflected in our earnings.”